Home
/
RXO, Inc.
/
Financials
/
Quarterly
RXO, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that RXO, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$1.42B
Nov 6, 2025
Q2
2025
Jun 30, 2025
$1.42B
Aug 7, 2025
Q1
2025
Mar 31, 2025
$1.43B
May 7, 2025
Q3
2025
Sep 30, 2024
$1.04B
Nov 6, 2025
Q2
2025
Jun 30, 2024
$930.00M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$913.00M
May 7, 2025
Q3
2024
Sep 30, 2023
$976.00M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$963.00M
Aug 7, 2024
Q1
2024
Mar 31, 2023
$1.01B
May 7, 2024
Q3
2023
Sep 30, 2022
$1.14B
Nov 7, 2023
Q2
2023
Jun 30, 2022
$1.23B
Aug 2, 2023
Q1
2023
Mar 31, 2022
$1.31B
May 3, 2023
Q3
2022
Sep 30, 2021
$1.20B
Nov 30, 2022
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($14.00M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($9.00M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($31.00M)
May 7, 2025
Q3
2025
Sep 30, 2024
($243.00M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($7.00M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($15.00M)
May 7, 2025
Q3
2024
Sep 30, 2023
($1.00M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
$3.00M
Aug 7, 2024
Q1
2024
Mar 31, 2023
$0
May 7, 2024
Q3
2023
Sep 30, 2022
$13.00M
Nov 7, 2023
Q2
2023
Jun 30, 2022
$44.00M
Aug 2, 2023
Q1
2023
Mar 31, 2022
$39.00M
May 3, 2023
Q3
2022
Sep 30, 2021
$33.00M
Nov 30, 2022
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($7.00M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
$0
Aug 7, 2025
Q1
2025
Mar 31, 2025
($30.00M)
May 7, 2025
Q3
2025
Sep 30, 2024
($20.00M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
$0
Aug 7, 2025
Q1
2025
Mar 31, 2024
($12.00M)
May 7, 2025
Q3
2024
Sep 30, 2023
$6.00M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$14.00M
Aug 7, 2024
Q1
2024
Mar 31, 2023
$5.00M
May 7, 2024
Q3
2023
Sep 30, 2022
$15.00M
Nov 7, 2023
Q2
2023
Jun 30, 2022
$58.00M
Aug 2, 2023
Q1
2023
Mar 31, 2022
$51.00M
May 3, 2023
Q3
2022
Sep 30, 2021
$38.00M
Nov 30, 2022